跳至主要内容
临床试验/JPRN-jRCT1080223380
JPRN-jRCT1080223380已完成Unknown

Special drug use surveillance of Takecab tablets for prevention of recurrence of gastric/duodenal ulcer in patients receiving low-dose aspirin:long-term use

Takeda Pharmaceutical Company Limited0 个研究点目标入组 1,119 人开始时间: 2016年11月16日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
入组人数
1,119

研究概览

简要总结

In conclusion, the present surveillance raised no new concerns about the safety or efficacy of Vonoprazan Tablets for up to 12 months in patients on low-dose aspirin, compared to the clinical study.

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • Participants with a history of gastric or duodenal ulcers

排除标准

  • Patients who meet any of the following criteria will not be included:
  • 1.Participants with gastric or duodenal ulcer at initiation of administration of Vonoprazan therapy
  • 2.Participants with active upper gastrointestinal hemorrhage at initiation of Vonoprazan therapy
  • 3.Participants with a history of any hypersensitivity to ingredients in Vonoprazan Tablets
  • 4.Participants receiving atazanavir sulfate or rilpivirine hydrochloride

研究者

相似试验

Special drug use surveillance of Vonoprazan for... | 临床试验